Atlas Trials

Hyperlipoproteinemia Type III

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hyperlipoproteinemia Type III

RecordFirmDate
Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia (NCT03811223)UMC Utrecht2019-08-01
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. (NCT00145431)Pfizer2005-03-01
Type III Dysbetalipoproteinemia (NCT00214604)AstraZeneca2005-02-01

Track Hyperlipoproteinemia Type III automatically

Every clearance here is in the API, with alerts when new ones post.